RESUMEN
Vitamin B6, a cofactor in many biochemical reactions in the cells of living organisms, is an essential coenzyme for various catabolic and anabolic processes. Although vitamin B6 deficiency in young healthy women with a balanced diet is thought to be unusual, it can be seen with certain medications, health conditions, and dietary deficits, as well as aging. Vitamin B6 deficiency is associated with a variety of ill health effects, and correction of deficiency is considered beneficial. Women particularly are affected by unique health issues that are part of the array of disorders potentially alleviated through vitamin B6 supplementation.
Asunto(s)
Necesidades Nutricionales , Deficiencia de Vitamina B 6/prevención & control , Vitamina B 6/uso terapéutico , Salud de la Mujer , Envejecimiento , Femenino , Humanos , Deficiencia de Vitamina B 6/tratamiento farmacológicoRESUMEN
OBJECTIVES: We investigated vitamin B6 blood concentrations in children on long-term dialysis at our centre. METHODS: Retrospective cross-sectional review of vitamin B6 blood concentrations in children on maintenance dialysis [peritoneal dialysis (PD), intermittent haemodialysis (IHD)]. RESULTS: We reviewed 28 children (16 boys), 15 IHD and 13 PD with median (interquartile range, IQR) age of 9.4 (2.4, 14.3) years. The median (IQR) vitamin B6 concentration was 223.4 (74.2, 392.8) nmol/L measured a median (IQR) of 9 (4, 16.5) months following commencement of dialysis. None of the children had vitamin B6 deficiency. Vitamin B6 concentrations were raised in 17 (61%), eight of these received a supplement. Nineteen (68%) received vitamin B6 and/or a supplement containing vitamin B6 whilst 11 (39%) received an enteral feed and a supplement. In those with normal vitamin B6 concentrations who were not receiving an enteral feed or an oral nutritional supplement (n = 6), all achieved normal concentrations without need for vitamin B6 supplementation. There were no differences between those on PD versus IHD (269.2 nmol/L vs. 130 nmol/L, P = 0.65). CONCLUSIONS: We report no children with vitamin B6 deficiency although > 50% had elevated vitamin B6 concentrations. We suggest if dietary assessment of vitamin B6 intake indicates insufficient intake, measurement of blood concentrations will help confirm if supplementation is required. Routine vitamin B6 supplementation and monitoring is currently not indicated in children on chronic dialysis.
Asunto(s)
Suplementos Dietéticos , Diálisis Renal/efectos adversos , Insuficiencia Renal Crónica/terapia , Deficiencia de Vitamina B 6/sangre , Vitamina B 6/sangre , Adolescente , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Lactante , Masculino , Insuficiencia Renal Crónica/complicaciones , Estudios Retrospectivos , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina B 6/etiología , Deficiencia de Vitamina B 6/prevención & controlRESUMEN
Vitamin B6 is important in fetal development, but little is known of the vitamin B6 status of pregnant women and newborns in North America and potential modifying factors. This prospective study determined maternal and cord plasma concentrations of pyridoxal 5' phosphate (PLP; an indicator of vitamin B6 status) in a convenience sample of 368 Canadian pregnant women and their newborns. The association of maternal intake of vitamin B6 and fetal genetic variants with cord plasma PLP and homocysteine concentrations was also examined. Dietary and supplemental intakes of vitamin B6 were assessed in early and mid to late pregnancy. PLP concentrations were measured in maternal plasma in early pregnancy and at delivery, and in cord plasma. Six fetal variants of the MTHFR and CßS genes were assessed for their association with cord plasma PLP and homocysteine concentrations. Geometric mean (95% CI) PLP concentrations were 107 (98, 116) nmol/L in early pregnancy and 58 (53, 62) nmol/L at delivery, respectively, and 296 (275, 319) nmol/L in cord blood (p < .0001). During early pregnancy and at delivery, 3.6% and 5.5% of women had plasma PLP concentrations <20 nmol/L, respectively. Ninety eight percent of the women with supplemental B6 intake of at least the recommended dietary allowance had PLP concentrations >20 nmol/L. Fetal genetic variants were not associated with cord PLP and homocysteine concentrations. Vitamin B6 deficiency is uncommon in a cohort of Canadian pregnant women due largely to prevalent vitamin B6 supplement use.
Asunto(s)
Dieta Saludable , Suplementos Dietéticos , Fenómenos Fisiologicos Nutricionales Maternos , Cooperación del Paciente , Fosfato de Piridoxal/sangre , Salud Urbana , Deficiencia de Vitamina B 6/prevención & control , Adulto , Estudios de Cohortes , Dieta Saludable/etnología , Femenino , Sangre Fetal/química , Humanos , Fenómenos Fisiológicos Nutricionales del Lactante/etnología , Recién Nacido , Masculino , Fenómenos Fisiologicos Nutricionales Maternos/etnología , Encuestas Nutricionales , Ontario/epidemiología , Cooperación del Paciente/etnología , Embarazo , Complicaciones del Embarazo/sangre , Complicaciones del Embarazo/epidemiología , Complicaciones del Embarazo/etnología , Complicaciones del Embarazo/prevención & control , Prevalencia , Fosfato de Piridoxal/deficiencia , Salud Urbana/etnología , Vitamina B 6/uso terapéutico , Deficiencia de Vitamina B 6/sangre , Deficiencia de Vitamina B 6/epidemiología , Deficiencia de Vitamina B 6/etnología , Adulto JovenRESUMEN
The water-soluble vitamins B6, B12 and C play important roles in maternal health as well as fetal development and physiology during gestation. This systematic review evaluates the risks and benefits of interventions with vitamins B6, B12 and C during pregnancy on maternal, neonatal and child health and nutrition outcomes. Relevant publications were identified by searching PubMed, Popline and Web of Science databases. Meta-analyses were conducted for outcomes where results from at least three controlled trials were available. Potential benefits of vitamin B6 supplementation were reduction in nausea and vomiting, improvement in dental health, and treatment of some cases of anaemia. In meta-analysis based on three small studies, vitamin B6 supplementation had a significant positive effect on birthweight (d = 217 g [95% confidence interval (CI) 130, 304]). Interventions with vitamin C alone or combined with vitamin E did not systematically reduce the incidence of pre-eclampsia, premature rupture of membranes, or other adverse pregnancy outcomes. In meta-analyses, vitamins C and E increased the risk of pregnancy-related hypertension (relative risk 1.10 [95% CI 1.02, 1.19]). Effects of vitamin B6 or C intervention on other neonatal outcomes, including preterm birth, low birthweight, and perinatal morbidity and mortality, were not significant. Data on child health outcomes were lacking. Despite the prevalence of vitamin B12 deficiency amongst populations with limited intake of animal source foods, no intervention trials have evaluated vitamin B12 supplementation before or during pregnancy. In conclusion, existing evidence does not justify vitamin C supplementation during pregnancy. Additional studies are needed to confirm positive effects of vitamin B6 supplementation on infant birthweight and other outcomes. While vitamin B12 supplementation may reduce the incidence of neural tube defects in the offspring based on theoretical considerations, research is needed to support this hypothesis.
Asunto(s)
Ácido Ascórbico/administración & dosificación , Protección a la Infancia , Suplementos Dietéticos , Fenómenos Fisiológicos Nutricionales del Lactante , Fenómenos Fisiologicos Nutricionales Maternos , Vitamina B 12/administración & dosificación , Vitamina B 6/administración & dosificación , Deficiencia de Ácido Ascórbico/prevención & control , Peso al Nacer , Preescolar , Femenino , Humanos , Lactante , Bienestar Materno , Preeclampsia/prevención & control , Embarazo , Complicaciones del Embarazo/prevención & control , Resultado del Embarazo , Ensayos Clínicos Controlados Aleatorios como Asunto , Deficiencia de Vitamina B 12/prevención & control , Deficiencia de Vitamina B 6/prevención & controlAsunto(s)
Antituberculosos/efectos adversos , Isoniazida/efectos adversos , Enfermedades del Sistema Nervioso/prevención & control , Complicaciones del Embarazo/prevención & control , Piridoxina/administración & dosificación , Complejo Vitamínico B/administración & dosificación , Femenino , Humanos , Embarazo , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Tuberculosis/tratamiento farmacológico , Deficiencia de Vitamina B 6/prevención & controlRESUMEN
Chronic diseases, including chronic renal insufficiency, predispose to deficiency of vitamin B-6. Prevalence of that phenomenon, the need and appropriate level of supplementation remain controversial. The paper is a review of literature concerning those topics. Causes of deficiency, as well as advantages and dangers of supplementation were referred.
Asunto(s)
Diálisis Renal/efectos adversos , Insuficiencia Renal Crónica/terapia , Deficiencia de Vitamina B 6/etiología , Deficiencia de Vitamina B 6/prevención & control , Vitamina B 6/uso terapéutico , Humanos , Insuficiencia Renal Crónica/complicaciones , Insuficiencia Renal Crónica/metabolismo , Vitamina B 6/metabolismoRESUMEN
OBJECTIVE: The study aimed to evaluate the dietary vitamin B6 intake and determine the vitamin B6 concentration in blood samples of German vegans. DESIGN AND SETTING: Cross-sectional study with 33 examination sites all over Germany. Subjects Ninety-three vegans (50 females) with a mean (+/- standard deviation (SD)) age of 43.7 +/- 15.7 years who took no vitamin supplements. METHODS: Dietary intake was assed using a semi-quantitative food-frequency questionnaire. Erythrocyte aspartate aminotransferase activity coefficient (EAST-AC) was calculated as the ratio of stimulated (pyridoxal 5'-phosphate added) to unstimulated activity in blood samples that were provided after an overnight fast. RESULTS: Mean +/- SD vitamin B6 intake was 2.83 +/- 0.98 mg day(-1) and mean +/- SD protein intake was 56.6 +/- 21.7 g day(-1). Of the participants 4% showed vitamin B6 intakes lower than daily recommended intakes for Germany, 16% showed EAST-AC > 1.85, and a further 58% showed EAST-AC of 1.5-1-85. Moderate vegans were affected to a lesser extent than strict vegans. None of the established confounders was a significant predictor of EAST-AC. In logistic regression analyses the contribution of nutriments and cereals to pyridoxine intake was the only predictor of EAST-AC classified as < or = 1.85 and > 1.85, respectively. CONCLUSIONS: In spite of the high total intake of vitamin B6, an adequate concentration in blood samples could not be realised for a majority of the participants. Due to the health implications of a marginal pyridoxine status, vegans should be encouraged to include foods with a high bioavailability of pyridoxine, such as beans, lentils and bananas, in the daily diet.
Asunto(s)
Dieta Vegetariana , Evaluación Nutricional , Estado Nutricional , Vitamina B 6/administración & dosificación , Vitamina B 6/sangre , Complejo Vitamínico B/administración & dosificación , Adulto , Aspartato Aminotransferasas/metabolismo , Disponibilidad Biológica , Estudios Transversales , Eritrocitos/enzimología , Femenino , Alemania , Humanos , Modelos Logísticos , Masculino , Encuestas y Cuestionarios , Deficiencia de Vitamina B 6/sangre , Deficiencia de Vitamina B 6/epidemiología , Deficiencia de Vitamina B 6/prevención & control , Complejo Vitamínico B/sangreRESUMEN
INTRODUCTION: Antituberculous treatment is effective but has numerous side effects. Among these isoniazid induced neuropathy is easily preventable. CASE REPORT: A female patient of 42 years, infected with HIV, presented with general deterioration associated with an interstitial pulmonary infiltrate and mediastinal lymphadenopathy. Tuberculosis was not confirmed bacteriologically but she responded to antituberculous treatment. Three months later she developed distal leg pains extending proximally. There was superficial sensory impairment up to the groins and loss of the ankle reflexes. The dose of isoniazid was reduced from 5 to 2.5 mg/kg/day on account of slow acetylator status and treatment with pyridoxine 250 mg/day commenced. The clinical signs resolved in a few weeks. CONCLUSIONS: Isoniazid neuropathy develops in the presence of risk factors (HIV, alcoholism, diabetes, renal failure, malnutrition, pregnancy and lactation, neurotoxic medication) and manifests itself initially by burning feet. Pyridoxine is preventative in low dosage and curative in high dosage. The development of symptoms should lead to measurement of acetylator status, and a reduction of the isoniazid dose to 3 mg/kg/day or even less in slow acetylators.
Asunto(s)
Antituberculosos/efectos adversos , Isoniazida/efectos adversos , Enfermedades del Sistema Nervioso Periférico/inducido químicamente , Deficiencia de Vitamina B 6/inducido químicamente , Vitamina B 6/uso terapéutico , Acetilación , Tendón Calcáneo , Adulto , Terapia Antirretroviral Altamente Activa , Antituberculosos/farmacocinética , Antituberculosos/uso terapéutico , Etambutol/administración & dosificación , Etambutol/uso terapéutico , Femenino , Guinea/etnología , Infecciones por VIH/complicaciones , Infecciones por VIH/tratamiento farmacológico , Hepatitis B Crónica/complicaciones , Humanos , Hipoestesia/inducido químicamente , Hipoestesia/tratamiento farmacológico , Hipoestesia/prevención & control , Inactivación Metabólica/genética , Isoniazida/administración & dosificación , Isoniazida/farmacocinética , Isoniazida/uso terapéutico , Enfermedades del Sistema Nervioso Periférico/tratamiento farmacológico , Enfermedades del Sistema Nervioso Periférico/prevención & control , Reflejo Anormal/efectos de los fármacos , Rifampin/administración & dosificación , Rifampin/uso terapéutico , Tuberculosis Pulmonar/tratamiento farmacológico , Vitamina B 6/farmacocinética , Deficiencia de Vitamina B 6/tratamiento farmacológico , Deficiencia de Vitamina B 6/prevención & controlAsunto(s)
Biotina , Deficiencia de Vitamina B 12/prevención & control , Vitamina B 12 , Deficiencia de Vitamina B 6/prevención & control , Vitamina B 6 , Deficiencia de Vitamina B/prevención & control , Biotina/administración & dosificación , Biotina/deficiencia , Humanos , Política Nutricional , Necesidades Nutricionales , Valor Nutritivo , Factores de Riesgo , Reino Unido , Vitamina B 12/administración & dosificación , Vitamina B 12/fisiología , Deficiencia de Vitamina B 12/etiología , Vitamina B 6/administración & dosificación , Vitamina B 6/fisiología , Deficiencia de Vitamina B 6/etiología , Deficiencia de Vitamina B/etiologíaRESUMEN
For more than 50 years, the Food and Nutrition Board of the National Academy of Sciences has been reviewing nutrition research and defining nutrient requirements for healthy people, referred to as the recommended dietary allowances (RDA). As new nutrition research is published, the importance of vitamins as vital nutrients is underscored, and new physiologic roles and applications to human health are examined and considered with regard to updating the RDA. Each year a substantial amount of research is published on vitamins. This article examines and summarizes noteworthy research published on individual water-soluble vitamins (excluding vitamin C) in the past 12 months, provides relevant background information on these vitamins, and offers critical reviews as appropriate.
Asunto(s)
Ácido Fólico/administración & dosificación , Ácido Fólico/fisiología , Complejo Vitamínico B/administración & dosificación , Complejo Vitamínico B/fisiología , Suplementos Dietéticos , Femenino , Ácido Fólico/química , Deficiencia de Ácido Fólico/complicaciones , Deficiencia de Ácido Fólico/prevención & control , Homocisteína/efectos de los fármacos , Homocisteína/metabolismo , Humanos , Masculino , Defectos del Tubo Neural/etiología , Defectos del Tubo Neural/prevención & control , Niacinamida/deficiencia , Niacinamida/fisiología , Niacinamida/uso terapéutico , Necesidades Nutricionales , Embarazo , Riboflavina/fisiología , Riboflavina/uso terapéutico , Deficiencia de Riboflavina/prevención & control , Solubilidad , Tiamina/fisiología , Tiamina/uso terapéutico , Deficiencia de Tiamina/prevención & control , Vitamina B 12/fisiología , Vitamina B 12/uso terapéutico , Deficiencia de Vitamina B 12/prevención & control , Vitamina B 6/fisiología , Vitamina B 6/uso terapéutico , Deficiencia de Vitamina B 6/prevención & control , Complejo Vitamínico B/química , Deficiencia de Vitamina B/prevención & controlAsunto(s)
Enfermedades Transmitidas por los Alimentos/etiología , Ginkgo biloba/toxicidad , Piridoxina/análogos & derivados , Animales , Biomarcadores/sangre , Enfermedades Transmitidas por los Alimentos/diagnóstico , Enfermedades Transmitidas por los Alimentos/prevención & control , Ginkgo biloba/química , Ginkgo biloba/envenenamiento , Humanos , Piridoxina/análisis , Piridoxina/sangre , Piridoxina/química , Piridoxina/toxicidad , Especificidad de la Especie , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina B 6/etiología , Deficiencia de Vitamina B 6/prevención & controlAsunto(s)
Metilación de ADN , Deficiencia de Ácido Fólico , Metionina/deficiencia , Selenio/deficiencia , Deficiencia de Vitamina B 12 , Deficiencia de Vitamina B 6 , Deficiencia de Ácido Fólico/diagnóstico , Deficiencia de Ácido Fólico/prevención & control , Deficiencia de Ácido Fólico/terapia , Enfermedades Hematológicas/diagnóstico , Enfermedades Hematológicas/prevención & control , Enfermedades Hematológicas/terapia , Humanos , Hiperhomocisteinemia/diagnóstico , Hiperhomocisteinemia/prevención & control , Enfermedad Iatrogénica/prevención & control , Metilación , Neoplasias/diagnóstico , Neoplasias/prevención & control , Enfermedades del Sistema Nervioso/diagnóstico , Enfermedades del Sistema Nervioso/prevención & control , Enfermedades Vasculares/diagnóstico , Enfermedades Vasculares/prevención & control , Deficiencia de Vitamina B 12/diagnóstico , Deficiencia de Vitamina B 12/prevención & control , Deficiencia de Vitamina B 12/terapia , Deficiencia de Vitamina B 6/diagnóstico , Deficiencia de Vitamina B 6/prevención & control , Deficiencia de Vitamina B 6/terapiaRESUMEN
A meta-analysis of the most representative Spanish nutrition studies was carried out to identify inadequate intakes of vitamins, A, B1, B6, C, E, folate, iron, and calcium in children aged 4 to 18. Information on vegetable, fruit and fruit juice/beverage intake was also solicited. Data drawn from the selected studies yielded a total of 6540 children and adolescents in eight geographical areas. The sample was stratified by age (children: 4 to 14 years old and adolescents: 13-18 years old) and sex. Inadequate intakes (below two-thirds of the recommended values) were notable in children for vitamin E, vitamin C, and vitamin A and in girls, iron. In adolescents, low intakes were especially marked for vitamin E and vitamin A, and in girls, calcium, folate, and iron. Adolescents consumed more vegetables, fruit juice, and fruit drinks whereas children had higher fruit intakes. Regional differences in consumption were also detected. Strategies for improving nutrient intake in these vulnerable populations are discussed.
Asunto(s)
Deficiencia de Ácido Ascórbico/epidemiología , Deficiencia de Ácido Ascórbico/prevención & control , Calcio/deficiencia , Deficiencia de Ácido Fólico/epidemiología , Deficiencia de Ácido Fólico/prevención & control , Deficiencias de Hierro , Deficiencia de Tiamina/epidemiología , Deficiencia de Tiamina/prevención & control , Deficiencia de Vitamina A/epidemiología , Deficiencia de Vitamina A/prevención & control , Deficiencia de Vitamina B 6/epidemiología , Deficiencia de Vitamina B 6/prevención & control , Deficiencia de Vitamina E/epidemiología , Deficiencia de Vitamina E/prevención & control , Adolescente , Bebidas , Niño , Preescolar , Registros de Dieta , Femenino , Frutas , Humanos , Masculino , Factores de Riesgo , Distribución por Sexo , España , VerdurasAsunto(s)
Antituberculosos/efectos adversos , Isoniazida/efectos adversos , Neuritis/inducido químicamente , Neuritis/prevención & control , Piridoxina/uso terapéutico , Deficiencia de Vitamina B 6/inducido químicamente , Deficiencia de Vitamina B 6/prevención & control , Adolescente , Factores de Edad , Niño , Preescolar , Quimioterapia Combinada , Femenino , Humanos , Lactante , Masculino , Resultado del TratamientoRESUMEN
The investigation of sufficiency of vitamin C, A, E, B2, B6, carotenoids and iron dietary intake has been carried out in 61 pregnant women in spring and early autumn 1998. There were no women adequately supplied with all vitamins irrespective of season and residence. Most of them (70-80 per cent) had combined deficiency of 3-5 vitamins in spring. About 50 per cent of women had combined insufficiency of vitamins and iron. Intake of vitamins improved in autumn especially due to vitamins C, A, E and carotenoids. The frequency of 3-5 vitamins deficit decreased while occurrence of combined deficiency of vitamin B6 and carotenoids still often took place. Thus, normalization of vitamin status of pregnant women is necessary all year round.
Asunto(s)
Avitaminosis , Complicaciones del Embarazo , Adulto , Avitaminosis/etiología , Avitaminosis/prevención & control , Carotenoides/deficiencia , Dieta , Femenino , Humanos , Hierro/administración & dosificación , Deficiencias de Hierro , Embarazo , Complicaciones del Embarazo/etiología , Complicaciones del Embarazo/prevención & control , Población Rural , Federación de Rusia , Estaciones del Año , Población Urbana , Deficiencia de Vitamina B 6/etiología , Deficiencia de Vitamina B 6/prevención & control , Vitaminas/administración & dosificaciónRESUMEN
Vitamin B6 is very important for the normal function of multiple organ systems. In the majority of patients with chronic renal failure and in patients during various forms of renal replacement therapy can develop vitamin B6 deficiency from many causes. Intravenous administration of 20 mg furosemide led to the increase of urinary excretion and fraction excretion (FE) of vitamin B6 in patients with chronic renal failure. This is a new side effect of furosemide. The daily oral dose of pyridoxine 6 mg was optimal for the patients without erythropoietin (EPO) treatment during the period of 12 months of CAPD. Erythrocyte vitamin B6 was determined by an indirect method, that is, by measuring the effect of pyridoxal-5-phosphate (PLP). In the other group of CAPD patients plasma vitamin B6 was in the reference range, and the mean value of peritoneal clearance of vitamin B6 was very low: 8.8% of urea clearance. In addition, an indirect relationship between the effect of PLP and plasma vitamin B6 was found. Indirect evidence has shown that erythrocyte vitamin B6 is consumed by the hemoglobin synthesis much more during EPO treatment in hemodialysis patients. No influence of pyridoxine 5 to 6 mg/day on decreased parameters of cellular immunity was found. For prevention of vitamin B6 deficiency in hemodialysis and CAPD patients we recommend the following doses of pyridoxine: for patients without EPO treatment 5 mg/day, and with EPO treatment 20 mg/day. A favorable effect of pyridoxine 50 mg/day has also been found on several parameters of cellular immunity in hemodialysis patients.
Asunto(s)
Fallo Renal Crónico/metabolismo , Piridoxina/metabolismo , Adulto , Diuréticos/administración & dosificación , Diuréticos/efectos adversos , Eritropoyetina/administración & dosificación , Furosemida/administración & dosificación , Furosemida/efectos adversos , Humanos , Inmunidad Celular , Inyecciones Intravenosas , Fallo Renal Crónico/terapia , Persona de Mediana Edad , Diálisis Peritoneal Ambulatoria Continua , Fosfato de Piridoxal/sangre , Fosfato de Piridoxal/uso terapéutico , Fosfato de Piridoxal/orina , Valores de Referencia , Deficiencia de Vitamina B 6/inducido químicamente , Deficiencia de Vitamina B 6/prevención & controlRESUMEN
Male rapidly growing broiler chicks were fed a moderate (22%) or a high protein (30%) well-balanced diet containing yeast Saccharomyces cerevisiae (2%) and consisting of soy protein isolate (Soyamin) or a purified amino acid mixture. The vitamin B6 status was assessed according to the in vitro stimulated activity of aspartic aminotransferase (activation coefficient; AC) and pyridoxal phosphate concentrations in plasma and erythrocytes. No weight difference was found between age-matched control and B6-deficient animals fed the Soyamin diet containing yeast. None of the deficient animals presented signs of malfunctions of the central nervous system. These animals grew well and their skeletal development was normal after 6 weeks of age. Due to the presence of yeast, increasing dietary protein intake did not augment the metabolic requirement for pyridoxine. The removal of yeast from the Soyamin diet provoked a severe symptomatic deficiency (AC 1.5). It seemed that yeast did more than promoting growth. It also protected against a lack of vitamin B6: feed utilization was not impaired. The present study showed that a low level of 0.6 mg vitamin B6/kg in a corn-Soyamin diet containing yeast was adequate to maintain normal growth and to avoid neurological symptoms. The pyridoxine requirement for normal growth and absence of convulsions has been reported to be approximately 3 mg/kg diet.
Asunto(s)
Alimentación Animal , Pollos/crecimiento & desarrollo , Proteínas en la Dieta/administración & dosificación , Piridoxina/metabolismo , Saccharomyces cerevisiae , Animales , Masculino , Proteínas de Vegetales Comestibles/administración & dosificación , Enfermedades de las Aves de Corral/prevención & control , Proteínas de Soja , Deficiencia de Vitamina B 6/prevención & control , Deficiencia de Vitamina B 6/veterinariaAsunto(s)
Países en Desarrollo , Isoniazida/administración & dosificación , Piridoxina/administración & dosificación , Tuberculosis Pulmonar/tratamiento farmacológico , Niño , Quimioterapia Combinada , Humanos , Isoniazida/efectos adversos , Enfermedades del Sistema Nervioso Periférico/inducido químicamente , Enfermedades del Sistema Nervioso Periférico/prevención & control , Desnutrición Proteico-Calórica/tratamiento farmacológico , Piridoxina/efectos adversos , Rifampin/administración & dosificación , Rifampin/efectos adversos , Factores de Riesgo , Deficiencia de Vitamina B 6/inducido químicamente , Deficiencia de Vitamina B 6/prevención & controlRESUMEN
According to our results the long-term daily oral supplementation of 6 mg vitamin B6 was sufficient for prevention of vitamin B6 deficiency in chronic renal failure, regular dialysis treatment and CAPD groups of patients. Haemodialysis and charcoal haemoperfusion have led to non-significant decrease of erythrocyte vitamin B6. A favourable effect was found of daily oral administration of 50 mg pyridoxine on electrophoretic mobility of peripheral blood lymphocytes and cellular immunity.